Quarter Period Statement Of Income

Daito Pharmaceutical Co., Ltd. - Filing #7719908

Concept 2018-06-01 to
2018-08-31
2017-06-01 to
2017-08-31
Quarter period statement of income
Statement of income
Net sales
9,739,969,000 JPY
9,681,572,000 JPY
Cost of sales
7,658,551,000 JPY
7,709,335,000 JPY
Gross profit (loss)
2,081,418,000 JPY
1,972,236,000 JPY
Selling, general and administrative expenses
986,282,000 JPY
1,041,210,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
1,093,839,000 JPY
932,098,000 JPY
Non-operating income
Interest income
56,000 JPY
320,000 JPY
Dividend income
32,932,000 JPY
31,932,000 JPY
Non-operating income
57,395,000 JPY
49,581,000 JPY
Non-operating expenses
Interest expenses
5,245,000 JPY
5,999,000 JPY
Non-operating expenses
9,739,000 JPY
8,111,000 JPY
Ordinary profit (loss)
1,141,496,000 JPY
973,568,000 JPY
Extraordinary income
Extraordinary income
JPY
20,524,000 JPY
Extraordinary losses
Extraordinary losses
JPY
146,000 JPY
Profit (loss) before income taxes
1,141,496,000 JPY
993,946,000 JPY
Income taxes
367,467,000 JPY
330,264,000 JPY
Profit (loss)
774,028,000 JPY
663,682,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.